Mauldin D, Roufogalis B D
Biochem J. 1980 May 1;187(2):507-13. doi: 10.1042/bj1870507.
Treatment of extensively washed erythrocyte membranes with 0.1mm-EDTA decreased their Mg(2+)-dependent, Ca(2+)-stimulated ATPase [(Mg(2+)+Ca(2+))-ATPase] activity. An activator released by this treatment restored the (Mg(2+)+Ca(2+))-ATPase to its original value in a Ca(2+)-dependent manner. This activator was different from calmodulin, as determined by a number of criteria. It was retained on an Amicon XM-100 ultrafiltration membrane (molecular-weight cut-off 100000); it appeared in the void volume of Sephadex G-100 and G-75 columns; it was not retained on a DEAE-cellulose ion-exchange column at ionic strengths similar to those used to retain calmodulin; and it maximally activated (Mg(2+)+Ca(2+))-ATPase activity less than calmodulin and at a higher Ca(2+) concentration. Like calmodulin, the activator is heat-stable. The activator fraction isolated on a 2.5-15% sucrose gradient in 0.16m-KCl showed a single band of mol.wt. 63000 and no calmodulin on 10%-polyacrylamide/sodium dodecyl sulphate gels. A trace amount of calmodulin was detected in the activator fraction by radioimmunoassay (approx. 10pg/ml of ;ghosts'), but this amount was insufficient to account for the (Mg(2+)+Ca(2+))-ATPase activation. Furthermore, calmodulin-binding protein failed to inhibit (Mg(2+)+Ca(2+))-ATPase activity by more than 10-20% in the membrane preparations from which the activator was extracted. It was concluded that erythrocyte membranes contain a (Mg(2+)+Ca(2+))-ATPase activator that may attenuate the activation of the Ca(2+)-transport ATPase by calmodulin.
用0.1mM - EDTA处理充分洗涤过的红细胞膜,会降低其镁离子依赖、钙离子刺激的ATP酶[(镁离子 + 钙离子)-ATP酶]活性。经此处理释放出的一种激活剂能以钙离子依赖的方式使(镁离子 + 钙离子)-ATP酶恢复到其初始值。通过多项标准确定,这种激活剂与钙调蛋白不同。它能保留在Amicon XM - 100超滤膜上(截留分子量100000);它出现在Sephadex G - 100和G - 75柱的空体积中;在与用于保留钙调蛋白相似的离子强度下,它不会保留在DEAE - 纤维素离子交换柱上;并且它对(镁离子 + 钙离子)-ATP酶活性的最大激活作用小于钙调蛋白,且在更高的钙离子浓度下。与钙调蛋白一样,该激活剂具有热稳定性。在0.16M - KCl中经2.5 - 15%蔗糖梯度分离得到的激活剂组分,在10% - 聚丙烯酰胺/十二烷基硫酸钠凝胶上显示出一条分子量为63000的单带,且无钙调蛋白。通过放射免疫测定法在激活剂组分中检测到微量的钙调蛋白(约10pg/ml的“血影”),但该量不足以解释(镁离子 + 钙离子)-ATP酶的激活。此外,钙调蛋白结合蛋白在从中提取激活剂的膜制剂中,对(镁离子 + 钙离子)-ATP酶活性的抑制作用未超过10 - 20%。得出的结论是,红细胞膜含有一种(镁离子 + 钙离子)-ATP酶激活剂,它可能会减弱钙调蛋白对钙离子转运ATP酶的激活作用。